Managing menopausal problems.
Cobleigh
M A
MA
Rush-Presbyterian-St. Luke's Medical Center, USA.
D000328:Adult; D000368:Aged; D000544:Alzheimer Disease / Q000517:prevention & control; D001943:Breast Neoplasms / Q000150:complications* / Q000188:drug therapy / Q000401:mortality; D002318:Cardiovascular Diseases / Q000401:mortality / Q000517:prevention & control; D015331:Cohort Studies; D004032:Diet; D004311:Double-Blind Method; D054278:Embryonal Carcinoma Stem Cells; D004967:Estrogens; D004968:Estrogens, Non-Steroidal / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D012739:Gonadal Steroid Hormones / Q000009:adverse effects / Q000627:therapeutic use; D020249:Hormone Replacement Therapy / Q000009:adverse effects; D019584:Hot Flashes / Q000188:drug therapy; D006801:Humans; D007529:Isoflavones; D008136:Longevity; D008593:Menopause; D008594:Menopause, Premature; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000139:chemically induced; D009376:Neoplasms, Hormone-Dependent; D016609:Neoplasms, Second Primary / Q000139:chemically induced; D014411:Neoplastic Stem Cells / Q000187:drug effects; D009765:Obesity / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy / Q000517:prevention & control; D048789:Phytoestrogens; D028321:Plant Preparations; D016032:Randomized Controlled Trials as Topic; D012449:Safety; D020845:Selective Estrogen Receptor Modulators / Q000009:adverse effects / Q000627:therapeutic use; D017741:Survivors; D015430:Weight Gain
D004967:Estrogens; D004968:Estrogens, Non-Steroidal; D012739:Gonadal Steroid Hormones; D007529:Isoflavones; D048789:Phytoestrogens; D028321:Plant Preparations; D020845:Selective Estrogen Receptor Modulators